Bedrosian Camille L (CIK 1326969) reported 9 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-22). Recent activity: Buy CRNX (5,925 shares), Buy AMLX (95,990 shares), Sell AMLX (6,461 shares), Sell AMLX (6,580 shares), Sell AMLX (12,039 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Buy | 5,925 | $0 |
| 2026-03-09 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | Buy | 95,990 | $0 |
| 2026-03-04 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | Sell | 6,461 | $94,201 |
| 2025-12-03 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | Sell | 6,580 | $94,423 |
| 2025-10-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | Sell | 12,039 | $175,529 |
| 2025-06-23 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Director | Buy | 4,000 | $0 |
| 2025-06-13 | Crinetics Pharmaceuticals, Inc. (CRNX) | Director | Buy | 6,900 | $0 |
| 2025-04-02 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | Sell | 12,425 | $43,115 |
| 2025-03-10 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Medical Officer | Buy | 68,420 | $0 |
Source: SEC Form 4 filings · as of 2026-06-22